768 related articles for article (PubMed ID: 22318237)
21. Therapeutic potential of peroxisome proliferator-activated receptors in chronic inflammation and colorectal cancer.
Wang D; DuBois RN
Gastroenterol Clin North Am; 2010 Sep; 39(3):697-707. PubMed ID: 20951925
[TBL] [Abstract][Full Text] [Related]
22. An overview on biological mechanisms of PPARs.
Kota BP; Huang TH; Roufogalis BD
Pharmacol Res; 2005 Feb; 51(2):85-94. PubMed ID: 15629253
[TBL] [Abstract][Full Text] [Related]
23. Pivotal Roles of Peroxisome Proliferator-Activated Receptors (PPARs) and Their Signal Cascade for Cellular and Whole-Body Energy Homeostasis.
Lamichane S; Dahal Lamichane B; Kwon SM
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29565812
[TBL] [Abstract][Full Text] [Related]
24. Roles of PPAR activation in cancer therapeutic resistance: Implications for combination therapy and drug development.
Zhang Y; Xiao B; Liu Y; Wu S; Xiang Q; Xiao Y; Zhao J; Yuan R; Xie K; Li L
Eur J Pharmacol; 2024 Feb; 964():176304. PubMed ID: 38142851
[TBL] [Abstract][Full Text] [Related]
25. Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the 'future' in dermatology therapeutics?
Gupta M; Mahajan VK; Mehta KS; Chauhan PS; Rawat R
Arch Dermatol Res; 2015 Nov; 307(9):767-80. PubMed ID: 25986745
[TBL] [Abstract][Full Text] [Related]
26. PPARs at the crossroads of lipid signaling and inflammation.
Wahli W; Michalik L
Trends Endocrinol Metab; 2012 Jul; 23(7):351-63. PubMed ID: 22704720
[TBL] [Abstract][Full Text] [Related]
27. Phytoceramide and sphingoid bases derived from brewer's yeast Saccharomyces pastorianus activate peroxisome proliferator-activated receptors.
Murakami I; Wakasa Y; Yamashita S; Kurihara T; Zama K; Kobayashi N; Mizutani Y; Mitsutake S; Shigyo T; Igarashi Y
Lipids Health Dis; 2011 Aug; 10():150. PubMed ID: 21861924
[TBL] [Abstract][Full Text] [Related]
28. Role of peroxisome proliferator-activated receptors in osteoarthritis (Review).
Huang G; Jiang W; Xie W; Lu W; Zhu W; Deng Z
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33355371
[TBL] [Abstract][Full Text] [Related]
29. The Role of PPARs in Disease.
Wagner N; Wagner KD
Cells; 2020 Oct; 9(11):. PubMed ID: 33126411
[TBL] [Abstract][Full Text] [Related]
30. Synthetic and natural Peroxisome Proliferator-Activated Receptor (PPAR) agonists as candidates for the therapy of the metabolic syndrome.
Tan CK; Zhuang Y; Wahli W
Expert Opin Ther Targets; 2017 Mar; 21(3):333-348. PubMed ID: 28092722
[TBL] [Abstract][Full Text] [Related]
31. [The role of peroxisome proliferator-activated receptors (PPAR) in carcinogenesis].
Knapp P; Jarzabek K; Błachnio A; Zbroch T
Ginekol Pol; 2006 Aug; 77(8):643-51. PubMed ID: 17076197
[TBL] [Abstract][Full Text] [Related]
32. Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons.
Cimini A; Benedetti E; Cristiano L; Sebastiani P; D'Amico MA; D'Angelo B; Di Loreto S
Neuroscience; 2005; 130(2):325-37. PubMed ID: 15664689
[TBL] [Abstract][Full Text] [Related]
33. Peroxisome proliferator-activated receptors and their relevance to dermatology.
Friedmann PS; Cooper HL; Healy E
Acta Derm Venereol; 2005; 85(3):194-202. PubMed ID: 16040401
[TBL] [Abstract][Full Text] [Related]
34. Minireview: Won't get fooled again: the nonmetabolic roles of peroxisome proliferator-activated receptors (PPARs) in the heart.
Lockyer P; Schisler JC; Patterson C; Willis MS
Mol Endocrinol; 2010 Jun; 24(6):1111-9. PubMed ID: 20016041
[TBL] [Abstract][Full Text] [Related]
35. Roles of PPARs in NAFLD: potential therapeutic targets.
Tailleux A; Wouters K; Staels B
Biochim Biophys Acta; 2012 May; 1821(5):809-18. PubMed ID: 22056763
[TBL] [Abstract][Full Text] [Related]
36. Targeting components of the stress system as potential therapies for the metabolic syndrome: the peroxisome-proliferator-activated receptors.
Yumuk VD
Ann N Y Acad Sci; 2006 Nov; 1083():306-18. PubMed ID: 17148746
[TBL] [Abstract][Full Text] [Related]
37. PPARs as targets for metabolic and cardiovascular diseases.
Cheng PT; Mukherjee R
Mini Rev Med Chem; 2005 Aug; 5(8):741-53. PubMed ID: 16101410
[TBL] [Abstract][Full Text] [Related]
38. PPARs modulate cardiac metabolism and mitochondrial function in diabetes.
Lee TW; Bai KJ; Lee TI; Chao TF; Kao YH; Chen YJ
J Biomed Sci; 2017 Jan; 24(1):5. PubMed ID: 28069019
[TBL] [Abstract][Full Text] [Related]
39. Elucidating the Beneficial Role of PPAR Agonists in Cardiac Diseases.
Khuchua Z; Glukhov AI; Strauss AW; Javadov S
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400386
[TBL] [Abstract][Full Text] [Related]
40. Targeting PPARs for therapy of atherosclerosis: A review.
Miao M; Wang X; Liu T; Li YJ; Yu WQ; Yang TM; Guo SD
Int J Biol Macromol; 2023 Jul; 242(Pt 2):125008. PubMed ID: 37217063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
